Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral dosing of GLP-1 compounds

Oral dosing of GLP-1 compounds

US Patent 12239739 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Glucose-sensitive albumin-binding derivatives2023
GLP-1 derivatives and uses thereof2023
Glucose sensitive insulins and uses thereof2023
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2022
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2022
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2022
Glucose-sensitive albumin-binding derivatives2021
Tablet formulation comprising a GLP-1 peptide and a delivery agent2021
Tablet formulation comprising a GLP-1 peptide and a delivery agent2021
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2021
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2021